Drug Development
Innocoll Announces Filing of Investigational New Drug Application for its CollaRx BUPIVACAINE IMPLANT for the Management of Post-Operative Pain
Published in Hospital Business Week, March 25th, 2007
Innocoll, Inc. announced that it has filed an Investigational New Drug (IND) application for its CollaRx(R) BUPIVACAINE IMPLANT, which is under development for the management of post-operative pain following moderate/major abdominal, gynecological, thoracic or orthopedic surgeries. The implant is a biodegradable and fully resorbable Bupivacaine Collagen Sponge formulated using Innocoll's proprietary CollaRx technology.
Post-surgical pain is typically controlled with narcotic analgesics such as morphine, but systemic administration of these drugs can result in unfavorable side effects including difficulty breathing, sedation, nausea and vomiting and can affect patients'...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Agency for Healthcare Research and Quality
AHRQ and Ad Council Encourage Patients to Ask Questions and Get More Involved With Their Health Care - AGFA Healthcare
Agfa HealthCare receives 2007 Frost & Sullivan North American Medical Informatics Competitive Strategy Leadership of the Year Award - American Shared Hospital Services
AMERICAN SHARED HOSPITAL SERVICES TO WITHDRAW PACIFIC EXCHANGE LISTING, RETAINS AMERICAN STOCK EXCHANGE LISTING - Anesthesia
Hand-Offs and Lack of Coordination During the Surgical Experience Contribute to High Rate of Harmful Medication Errors - Aneurysm
Medtronic Submits Pre-Market Approval Application to the FDA for the Talent Thoracic Stent Graft System - Arrhythmia
New Study Finds Commonly Used Heart Monitoring System Often Fails to Detect Serious Cardiac Arrhythmias, a Leading Cause of Stroke and Sudden Cardiac Death - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
